No CrossRef data available.
Article contents
2314 – Psychiatric Comorbidity And Quality Of Life In Patients With Beta Thalassemia Major
Published online by Cambridge University Press: 15 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective
The study is aimed to assess quality of life, anxiety and depression levels and investigate the rate of psychiatric disorder in adolescent and young adults with beta Thalassemia major.
Methods
Sample includes 43 patients with β-thalassemia major. Patients were screened by Structured Interview for DSM-IV (SCID-I), Short Form-36 (SF-36) and Hospital Anxiety and Depression Scale (HAD).
Results
Fourty two percent of the patients suffered from a psychiatric disorder. The most common psychiatric disorders were social anxiety disorder (%21) and generalized anxiety disorder (%12). Significantly lower quality of life was found on all 8 SF-36 domains for β-thalassemia major and psychiatric comorbidity patients compared to no-comorbidity patients.The correlation between HAD and SF-36 scores was statistically significant.
Conclusion
Psychiatric disorders are significantly related to impaired quality of life. The correlations between anxiety, depression levels and SF-36 scores indicate that high depressive and anxiety levels are associated with reduced quality of life.
- Type
- Abstract
- Information
- European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E1450
- Copyright
- Copyright © European Psychiatric Association 2012
You have
Access
Comments
No Comments have been published for this article.